News
Hosted on MSN10mon
Globus Medical gets FDA approval for two knee replacement productsGlobus Medical, Inc. (GMED) Q1 2024 Earnings Call Transcript Globus Medical up 11% on guidance boost, Q1 results Globus Medical Non-GAAP EPS of $0.72 beats by $0.15, revenue of $606.67M beats by ...
Globus Medical ... with Total Knee Arthroplasty (“TKA”) application has received 510(k) clearance from the Food and Drug Administration (“FDA”). The ACTIFY 3D Total Knee System has ...
July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE ... and procedural flexibility in Total Knee Arthroplasty. Additionally, ACTIFY™ 3D Total Knee System, the latest in implant ...
Hosted on MSN10mon
Globus Medical Gains FDA Clearance for New Knee Surgery TechnologyAUDUBON, PA — Globus Medical, Inc. (NYSE ... and procedural flexibility in knee surgeries. The company also announced that the ACTIFY™ 3D Total Knee System, designed to pair with ExcelsiusFlex ...
AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of ...
March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal ... the ExcelsiusFlex™ surgical robotic navigation system for Total Knee Arthroplasty (TKA), alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results